Marker Therapeutics (MRKR) Invested Capital (2010 - 2022)
Marker Therapeutics (MRKR) posted quarterly Invested Capital of $2.5 million for Q4 2022, down 50.5% quarter-over-quarter from $5.0 million in Q3 2022.
Marker Therapeutics (MRKR) Invested Capital (2010 - 2022) Analysis & Trends
Marker Therapeutics (MRKR) has reported Invested Capital for 6 consecutive years, with $2.5 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Invested Capital changed N/A year-over-year to $2.5 million; the TTM figure through Sep 2023 stood at $2.5 million (down 80.84% YoY), while the FY2022 annual figure was $2.5 million, changed N/A from the prior year.
- Invested Capital eased to $2.5 million in Q4 2022 per MRKR's latest filing, from $5.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $8.0 million in Q2 2022 and bottomed at $2.5 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Marker Therapeutics | 27.04 Mn | 15.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 5.05 Mn |
| Jun 30, 2022 | 8.00 Mn |
| Mar 31, 2014 | 81,000.00 |
| Dec 31, 2013 | 369,346.00 |
| Sep 30, 2013 | 10,000.00 |
| Mar 31, 2013 | 153,846.00 |
| Dec 31, 2012 | 10,000.00 |
| Sep 30, 2012 | 28,000.00 |
| Jun 30, 2012 | 220,698.00 |
| Mar 31, 2012 | 293,805.00 |
| Dec 31, 2011 | 7,000.00 |
| Sep 30, 2011 | 7,000.00 |
| Jun 30, 2011 | 100,000.00 |
| Dec 31, 2010 | 259,305.00 |